Antonija Kolobaric

Antonija Kolobaric

Auto-generated profile, based on publicly available information

Antonija Kolobaric


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2022 in NeuroImage
Verified
Journal Article
Open access
YCYoungsun T. Cho
Youngsun T. Cho
FMFlora Moujaes
Flora Moujaes
CSCharles H. Schleifer
Charles H. Schleifer
MSMartina Starc
Martina Starc
JJJie Lisa Ji
Jie Lisa Ji
AAAlan Anticevic
Alan Anticevic
Integrating motivational signals with cognition is critical for goal-directed activities. The mechanisms that link neural changes with motivated working memory continue to be understood. Here, we tested how externally cued and non-cued (internally represented) reward and loss impact spatial working memory precision and neural circuits in human subjects using fMRI. We translated the classic delayed-response spatial working memory paradigm from non-human primate studies to take advantage of a continuous numeric measure of working memory precision, and the wealth of translational neuroscience yielded by these studies. Our results demonstrated that both cued and non-cued reward and loss improved spatial working memory precision. Visual association regions of the posterior prefrontal and parietal cortices, specifically the precentral sulcus (PCS) and intraparietal sulcus (IPS), had increased BOLD signal during incentivized spatial working memory. A subset of these regions had trial-by-trial increases in BOLD signal that were associated with better working memory precision, suggesting that these regions may be critical for linking neural signals with motivated working memory. In contrast, regions straddling executive networks, including areas in the dorsolateral prefrontal cortex, anterior parietal cortex and cerebellum displayed decreased BOLD signal during incentivized working memory. While reward and loss similarly impacted working memory processes, they dissociated during feedback when money won or avoided in loss was given based on working memory performance. During feedback, the trial-by-trial amount and valence of reward/loss received was dissociated amongst regions such as the ventral striatum, habenula and periaqueductal gray. Overall, this work suggests motivated spatial working memory is supported by complex sensory processes, and that the IPS and PCS in the posterior frontoparietal cortices may be key regions for integrating motivational signals with spatial working memory precision.

30 August 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
AKAntonija Kolobaric
Antonija Kolobaric
SHSusan Hewlings
Susan Hewlings
CBCorey Bryant
Corey Bryant
CCChristopher Colwell
Christopher Colwell
CDChristopher D'adamo
Christopher D'adamo
EPEmily K Pauli
Emily K Pauli
Inadequate sleep is a global health concern. Sleep is multidimensional and complex; new multi-ingredient agents are needed. This study assessed the comparative effects of two multi-ingredient supplements on sleep relative to placebo. Adults (N = 620) seeking better sleep were randomly assigned to receive one of three study products. Sleep A (contained lower (0.35 mg THC and higher levels of botanicals (75 mg each hops oil and valerian oil), Sleep B (contained higher THC (0.85 mg) and lower botanicals (20 mg each hops oil and valerian oil) or placebo) for 4 weeks. Sleep disturbance was assessed at baseline and weekly using NIH’s Patient-Reported Outcomes Measurement Information System (PROMIS™) Sleep Disturbance SF 8A survey. Anxiety, stress, pain, and well-being were assessed using validated measures at baseline and weekly. A linear mixed-effects regression model was used to assess the change in health outcome score between active product groups and the placebo. There was a significant difference in sleep disturbance, anxiety, stress, and well-being between Sleep A and placebo. There was no significant difference in any health parameter between Sleep B and placebo. Side effects were mild or moderate. There were no significant differences in the frequency of side effects between the study groups. A botanical blend containing a low concentration of THC improved sleep disturbance, anxiety, stress, and well-being in healthy individuals that reported better sleep as a primary health concern.

24 July 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
AKAntonija Kolobaric
Antonija Kolobaric
JSJessica Saleska
Jessica Saleska
SHSusan Hewlings
Susan Hewlings
CBCorey Bryant
Corey Bryant
CCChristopher Colwell
Christopher Colwell
EPEmily K Pauli
Emily K Pauli
The phytocannabinoid cannabinol (CBN) has a potential mechanism of action as an alternative sleep aid but there is minimal evidence to support its effectiveness. The aim of this randomized, double-blind, placebo-controlled study was to assess the safety and effects of three formulations of a hemp-derived CBN sleep aid, TruCBN™ [25 mg (n = 206), 50 mg (n = 205), 100 mg (n = 203)], on sleep quality (PROMIS Sleep Disturbance 8A), relative to placebo (n = 204). The effectiveness and safety of these formulations relative to 4 mg of melatonin (n = 202) was assessed. Exploratory measures were stress (PROMIS Stress 4A), anxiety (Anxiety 4A), pain (PROMIS™ PEG), and well-being (WHO 5). All groups and the 4 mg melatonin group experienced significant improvement in sleep quality relative to the placebo group with no significant differences between any group and the melatonin group. Participants taking 100 mg showed a larger decrease in stress compared to the placebo group. There were no significant differences in anxiety, pain, well-being, or the frequency of side effects between any group and the placebo group. There was no significant difference in improvements in sleep quality between any of the treatment groups and the 4 mg melatonin group. Orally ingested CBN, at 25 mg, 50 mg, and 100 mg, is a safe and effective alternative for the improvement of sleep.

20 March 2023 in Journal of Psychiatric Research
Verified
Journal Article
Closed access
AKAntonija Kolobaric
Antonija Kolobaric
AMAkiko Mizuno
Akiko Mizuno
YXYang Xiao
Yang Xiao
CGCharles J. George
Charles J. George
ASAndrew Seidman
Andrew Seidman
HKHelmet Karim
Helmet Karim

15 September 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
SMSarah K. Munyoki
Sarah K. Munyoki
JGJulie P. Goff
Julie P. Goff
ARAmanda Reshke
Amanda Reshke
EWErin Wilderoter
Erin Wilderoter
NMNyasha Mafarachisi
Nyasha Mafarachisi
EJEldin Jašarević
Eldin Jašarević
Infertility is a devastating condition affecting one in six people globally. In many cases, the underlying causes are unknown. Emerging evidence suggests that the microbiota influences reproduction, yet the mechanistic link between the microbiota, ovarian function, and length of the fertile lifespan remain unexplored. Here we report that the microbiota controls the length of the reproductive lifespan by maintaining the primordial follicle pool, a process mediated by microbiota-derived short chain fatty acids modulating gene regulatory networks crucial for the survival of the ovarian reserve. Dietary perturbation of the microbiota during a critical developmental window is sufficient to diminish the ovarian reserve, reduce oocyte retrieval, and impair preimplantation embryo viability, mirroring challenges in human fertility treatments. Targeted interventions to restore microbiota improve assisted reproductive outcomes, particularly when implemented early. These findings reveal a novel contribution of host-microbe interactions in mammalian reproduction and demonstrate that the microbiota impacts ovarian function and fertility.

10 April 2023 in Biological Psychiatry
Verified
Journal Article
Open access
PDF file
AKAntonija Kolobaric
Antonija Kolobaric
CACarmen Andreescu
Carmen Andreescu
EJEldin Jasarevic
Eldin Jasarevic
HAHoward Aizenstein
Howard Aizenstein
CHChang Hyung Hong
Chang Hyung Hong
SSSang Joon Son
Sang Joon Son
The presence of depressive symptoms in older adults with cognitive decline decreases quality of life and increases likelihood of progression to dementia. Microbiome differences have been associated to varying degrees with both depressive symptoms and cognitive decline, but these associations are poorly understood. We investigated the predictive role of gut microbiome in association to cognitive decline, and depressive symptoms.